Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Operating Leases (2019 - 2025)

BioCorRx (BICX) has disclosed Operating Leases for 7 consecutive years, with $159127.0 as the latest value for Q4 2025.

  • Quarterly Operating Leases changed 0.0% to $159127.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $159127.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $159127.0 for FY2025, 0.0% changed from the prior year.
  • Operating Leases hit $159127.0 in Q4 2025 for BioCorRx, up from $839.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $516132.0 in Q1 2021 to a low of $839.0 in Q3 2025.
  • Historically, Operating Leases has averaged $208584.4 across 5 years, with a median of $174499.0 in 2024.
  • Biggest five-year swings in Operating Leases: skyrocketed 1353.88% in 2024 and later tumbled 99.5% in 2025.
  • Year by year, Operating Leases stood at $315672.0 in 2021, then crashed by 42.56% to $181328.0 in 2022, then crashed by 93.96% to $10945.0 in 2023, then surged by 1353.88% to $159127.0 in 2024, then changed by 0.0% to $159127.0 in 2025.
  • Business Quant data shows Operating Leases for BICX at $159127.0 in Q4 2025, $839.0 in Q3 2025, and $137869.0 in Q2 2025.